1 |
Gopalan, P., Tsuji, T., Lehmann, K., Kimura, M., Shinozuka, H., Sato, K., and Lotlikar, P. D., Modulation of aflatoxin -induced glutathione S-transferase placental from positive hepatic foci by pretreatment of rats with phenobarbital and buthionine sulfoximine. Carcinogenesis., 14, 1469-1470 (1993)
DOI
ScienceOn
|
2 |
Habig, W. H., Pabst, M. J., and Jakoby, W. B., Glutathione Stransferase: the first enzymatic step in mercaturic acid formation, J.Biol. Chem., 249, 7130-7139 (1974)
PUBMED
|
3 |
Johnson, W. W. and Guengerich, F. P., Reaction of aflatoxin , exo-8.9-epxide with DNA: kinetic analysis of 60 ralent binding and DNA induced hydrolysis. Proc. Natl. Acad. Sci. U.S.A., 94, 6121-6125 (1997)
DOI
ScienceOn
|
4 |
Jung, M. Y., Kwon, S. K., and Moon, A., Chemopreventive allylthiopyridazine derivatives induce apoptosis in SK-Hep-1 hepatocarcinoma cells through a caspase-3-dependent mechanism. Eur. J. Cancer, 37, 2104-2110 (2001)
DOI
ScienceOn
|
5 |
Lee, J. I., Park, H., Yun, Y., S. and Kwon, S. K., An efficient synthesis of 3-alkoxy-6-allylthiopyridazines. J. Kor. Chem. Soc., 45, 386-390 (2001)
|
6 |
Metcalfe, S. A., Colley, P. J., and Neul, G. E., A comparison of the effects of pretreatment with phenobarbitone and 3-methyl cholanthrene an the metabolism of AF by rat liver microsme and isolated hepatocytes in vitro. Chem. Biol. Interact., 35, 145-157 (1981)
DOI
ScienceOn
|
7 |
Toskulkao, C., Yoshida, T., Glinsulkon, T., and Kuroiwa, Y., Potentiation of aflatoxin induced hepatotoxicity in male Wistar rats with ethanol pretreatment. J. Toxicol. Sci., 141, 141-151 (1996)
|
8 |
Wang, J. C., Shen, X., He, X., Zhu, Y. S., Zhang, B. C., Wnag, J. B., Qian, G. S., Kuang, S. Y., Zarba, A., Egaer, D. A., Jacobson, L. P., Munoz, A., Helzlsourer, K. J., Groopman, J. D., and Kensler, T. W., Protective alterations in phase 1 and 2 metabolism of aflatoxin by oltipraz residents of Q1 dong, Peoples Republic of China. J. Natl. Cancer. Inst., 117, 2347-2354 (1999)
|
9 |
Kwon, S. K., Synthesis of 4,5-substituted 3-alkoxy-6-allylthiopyridazine derivatives. Yakhak Hoeji, 46, 155-160 (2002)
|
10 |
Johnson, W. W., Harris, T. M., and Guengerich, F. P., Kinetics and mechanism of hydrolysis of aflatoxin exo-8,9-oxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc., 118, 8213-8220 (1996)
|
11 |
Manson, M. M., Hudson, E. A., Ball, H. W., Burrett, M. C., Clack, H. L., Judah, D. J., Verschoyle, R. D., and Neal, G. E., Chemoprevention of aflatoxin -induced carcinogenesis by indole-s-carbinol in rat liver-predicting the outcome using early biomarkers. Carcinogenesis, 1829-1836 (1998)
PUBMED
|
12 |
Reitman, S. and Frankel, S., A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Pathol., 28, 56-60 (1957)
DOI
PUBMED
|
13 |
Blanchette-Mackie, E. J., Dwyer, N, K., and Amende, L. A., Cytochemical studies of lipid metabolism: immunologold probes for lipidprotein lipase and cholesterol. Am. J. Amat., 185, 255-263 (1989)
|
14 |
Gorelick, N. J., Risk assessment for aflatoxin: I. Metabolism of aflatoxin by different species. Risk. Anal., 10, 539-559 (1990)
DOI
ScienceOn
|
15 |
Lowery, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. T., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 295-275 (1951)
|
16 |
Ishii, K., Maeda, K., Kamatake, T. and Kato, R., Mutagenic activation of aflatoxin by several forms of purified cytochrom P450. Mutat. Res., 174, 85-88 (1986)
DOI
ScienceOn
|
17 |
Sheweita, S. A., Abd El-Gagar, M., and Bastawy, M., Carbon tetrachloride-induced changes in the activity of phase II drugmetabolizing enzyme in the liver of male rat role of oxidants. Toxicology, 165, 217-224 (2001)
DOI
PUBMED
ScienceOn
|
18 |
Gallagher, E. P., Wienkers, L. C., Stapleton, P. L., Kunze, K. L., and Eaton, D. L., Role of Human microsomal and human complementary DNA-expressed cytochromes P450 3A4 in the bioactivation of aflatoxin . Cancer Res., 54, 101-108 (1994)
PUBMED
|
19 |
Bradford, M. M., A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976)
DOI
PUBMED
ScienceOn
|
20 |
Knight, L. P., Primiano, T., Groopman, J. D., Kensler, T. W., and Sutter, T. R., cDNA cloning, expression and activity of a second human aflatoxin -metabolizing member of the aldoketo reductase superfamily, AKR7A3. Carcinogenesis, 20, 1215-23 (1999)
DOI
ScienceOn
|
21 |
Towner, R. A., Hashimoto, H., and Summers, P. H., Non-invasive in vivo magnetic resonance imaging assessment of acute aflatoxin hepatotoxicity in rats. Biochim. Biophys. Acta, 1475, 314-320 (2000)
DOI
PUBMED
ScienceOn
|
22 |
Ha, T. G., Jang, J. J., Kim, S. G., and Kim, N. D., 2-(Allylthio) pyrazine inhibition of aflatoxin -induced hepatocarcinogenesis in rat. Chem. Biol. Interact., 121, 209-222 (1999)
DOI
ScienceOn
|
23 |
Gyamfi, M. A. and Anja, Y., Medicinal herb, Thonningia sanguinea protects against aflatoxin acute hepatotoxicity in Fischer rats. Hum. Exp. Toxicol., 17, 418-423 (1996)
DOI
ScienceOn
|
24 |
Primiano, P. E., Egner, Sutter, T. R., Kelloff, G. J., Roebuck, B. D., and Kensler, Y. W., Intermittent dosing with oltipraz : relationship between chemprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res., 44, 4319-4324 (1995)
|
25 |
Manson, M. M., Bell, H. W. L., Barrett, M. C., Clark, H. L., Judah, J. J., Williamson, G., and Neal, G. E., Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and phase II drug metabolizing enzymes and aflatoxin metabolism. Carcinogenesis, 18, 1729-1738 (1997)
DOI
ScienceOn
|
26 |
Judah, D. J., Hayes, J. D., Yang, T. C., Lian, L. Y., Roberts, G. K., Famer, P. P., Lamb, T. H., and Neal, G. E., Anorel aldehydereductase with activity towards a metabolite of aflatoxin is expressed in rat liver during carcinogenesis and following the administration of an antioxidant. Biochem. J., 292, 13-18 (1993)
DOI
PUBMED
|
27 |
Ueng, Y. F., Shinada, T., Yamazaki, H., and Guengrich, F. P., Oxidation of aflatoxin by bacterial recombinant Human cytochrome P450 enzymes. Chem. Res. Toxicol., 8, 218-225 (1995)
DOI
ScienceOn
|